SUNESIS PHARMACEUTICALS INC
(867328700)
Fondsberichterstattung Bestände von SUNESIS PHARMACEUTICALS INC gemäß 13F Anmeldungen
Firmenname | Gehaltene Aktien / Nennbetrag | Marktwert | Möglichkeit | Berichtszeitraum | Gültigkeitsdatum |
---|---|---|---|---|---|
Nantahala Capital Management LLC | 4,458,824 | $3,241k | Jun 30, 2019 | Aug 14, 2019 | |
Point72 Asset Management LP | 1,400,000 | $1,018k | Jun 30, 2019 | Aug 14, 2019 | |
PALO ALTO Investors LP | 1,162,473 | $845k | Jun 30, 2019 | Aug 14, 2019 | |
Baker BROS Advisors LP | 556,665 | $405k | Jun 30, 2019 | Aug 14, 2019 | |
First Eagle Investment Management LLC | 294,480 | $214k | Jun 30, 2019 | Aug 13, 2019 | |
Telemetry Investments LLC | 61,000 | $44k | Jun 30, 2019 | Aug 14, 2019 |